Probiotics from the pharmacy or pharmabiotics: what's the difference and what really works?

Біговий захід GoMove в Ужгороді за підтримки Ediens

Introduction

The crisis of “blind” prescribing In modern medical practice, taking antibiotics is often compared to “carpet bombing” of the gastrointestinal tract: the drugs destroy both pathogenic and vital beneficial bacteria, leaving the mucous membrane empty and vulnerable to colonization by opportunistic pathogens. It is natural that doctors and patients turn to probiotics to restore the microbiota. However, today we are faced with a global problem: the massive and uncontrolled, “blind” prescription of pharmacy probiotics without prior analysis of the microbiome often not only does not bring benefits, but can also cause harm.

Classical medicine is increasingly criticized for its protocol approach, when patients with different microbiome profiles are prescribed the same standard drugs. At the same time, innovative 4P medicine (personalized, predictive, preventive, patient-centered) proves that the microbiome is a unique human “superorgan”, and its correction requires a completely different, targeted approach using new generation biologics — pharmabiotics.

The Illusion of Pharmacy Multiprobiotics: Why "More" Doesn't Mean "Better"

In the modern pharmaceutical market, there is a trend towards the creation of so-called "multi-strain" probiotics. Manufacturers can combine 15, 20, and sometimes even 36 different strains of microorganisms in one capsule, guided by the marketing logic of "the more, the better." However, from the point of view of clinical microbiology, this approach is wrong.

As scientists note, introducing a huge number of diverse foreign bacteria into the intestinal ecosystem resembles a situation when dozens of new people are suddenly herded into a crowded club.

Once in the gastrointestinal tract, these bacteria begin fierce competition for resources and ecological niches. As a result, they can aggressively suppress not only pathogens, but also the remnants of your own, native (commensal) microflora, which is the body's most valuable immunological asset.

In addition, many mass-market probiotics often contain insufficient amounts of live bacteria and a lot of excipients ("powder"), and act only as "transit" passengers: they pass through the body, creating a temporary effect, but do not take root and do not perform a supporting function after the end of the intake. Moreover, without prior analysis, you are actually acting "at random" - consuming bacteria that your body may not need at all, thereby stimulating the development of dysbiosis.

Pharmabiotics: new generation biologics with proven efficacy

To address the ineffectiveness of conventional probiotics, scientists have developed pharmabiotics. The term “pharmabiotics” itself was coined to refer to biological products (probiotics) that have clearly proven clinical effects and are used for the predicted correction of physiological conditions.

Unlike conventional probiotics, which are often created by companies to order and only then undergo limited testing, the development of pharmabiotics goes the other way around. First, multi-year clinical trials and cohort studies (which last for years and become the basis of scientific dissertations) are conducted, during which specific nosologies are studied. And only after proving effectiveness, a specific composition of strains is created.

The main differences and advantages of pharmabiotics:

Targeted action (Targeting): Pharmabiotics are selected according to a strict rule - they must purposefully inhibit (suppress) the growth of opportunistic microorganisms that are triggers of inflammation, but at the same time absolutely do not suppress (and ideally stimulate) the growth of the patient's beneficial commensals.
High concentration and survival: Pharmabiotics contain high concentrations of viable cells (from 108 to 1010 CFU), which is significantly higher than the average pharmacy analogues (107–108 CFU). Thanks to special encapsulation technologies (for example, acid-resistant capsules), they successfully overcome the aggressive environment of the stomach and reach the site of localization unchanged.
Niche: There are specialized pharmabiotics not only for the intestines, but also for the skin (treatment of atopic dermatitis, acne), the oral microbiome (elimination of bad breath, prevention of caries), the genitourinary system (fighting vaginosis) and even for reducing the effects of stress (" Metabolic anti-stress ").

Personalization: The foundation of successful therapy

For the drug to really work, it must be selected individually based on an in-depth study of the patient's microbiota. This allows you to establish a "diagnostic ratio" - a unique formula of the microbiome of a particular person, and identify which bacteria are missing and which cause pathology (their proven etiological role).

Modern microbiological diagnostics allows for so-called manual selection: before the patient starts taking the drug, the patient's own microorganisms are tested in vitro to see how they will react to a specific pharmabiotic or probiotic. This eliminates the "trial and error" method and guarantees the effectiveness of the therapy (predicted correction).

An important aspect is the mode of administration. Scientists categorically do not recommend taking probiotics or pharmabiotics continuously. The optimal course is 14 days, after which it is necessary to take a break for 10–14 days. Continuous oversaturation of the body with beneficial strains can lead to "dysbacteriosis from good" and the effect of addiction, when the drug ceases to work.

Autoprobiotics: an individual microbiota bank as the highest form of personalization

Despite the high effectiveness of pharmabiotics, the most valuable "currency" for human health is your own, natural (commensal) microorganisms, inherited from your ancestors. They are perfectly adapted to your genetics, immune system, and metabolism.

Today, the most modern solution in the world is autoprobiotic therapy and the creation of an " Individual Microbiota Bank ". The patient provides a microbiota sample during a period of relative health. The laboratory isolates beneficial bacteria, cultivates them and preserves (freezes) them in a biobank. If in the future a person experiences severe stress, undergoes a course of massive antibiotic therapy or chemotherapy, he will be able to restore his microbiome with the help of his own "native" bacteria.

The main and undeniable advantage of autoprobiotics is their absolute immunological tolerance. The immune system perceives them as "one's own", they instantly take root and persist in the body for a long time, without causing any adverse reactions or conflicts in the microbial coenosis.

Conclusions

Conventional probiotics from the pharmacy are often a mass marketing tool that does not take into account the individual characteristics of the patient's microbiome. Blindly prescribing multi-strain drugs can exacerbate dysbiosis and suppress the patient's own beneficial microflora. In contrast, pharmabiotics are drugs with proven clinical efficacy that are used for targeted correction of the microbiome after accurate diagnosis. Together with the technology of autoprobiotics (microbiota banks), they form the foundation of 4P medicine, allowing to restore the immune barrier, normalize the work of the gut-brain axis, and return the patient to physiological and mental health.

Short questions and answers on the topic (Q&A)

1. What is the main difference between regular probiotics from the pharmacy and pharmabiotics?

Answer: Conventional probiotics are often food supplements formulated without taking into account individual needs, which can only act as "transit" bacteria. Pharmabiotics are new generation biological preparations with proven clinical efficacy, developed on the basis of many years of research. Their goal is to specifically inhibit (destroy) pathogenic microorganisms, without suppressing your own beneficial bacteria.

2. Why can multiprobiotics, which contain 20-30 different strains, be harmful?

Answer: Introducing a large number of foreign strains at once leads to fierce competition in the gut. These bacteria begin to fight for survival and can aggressively suppress the remnants of your native, beneficial microflora, disrupting the natural balance of the ecosystem.

3. How long do I need to take pharmabiotics and can I take them constantly?

Answer: A scientifically based approach requires a course of treatment: usually 14 days of continuous use, after which a break of 10–14 days is necessarily taken. Constant, continuous intake of even beneficial bacteria leads to oversaturation of the body and can cause the so-called "dysbacteriosis from good" and the habituation effect.

4. What is an Individual Microbiota Bank (autoprobiotics) and why is it needed?

Answer: This is an innovative technology for preserving your own "native" beneficial bacteria. During the period of health, the bacteria are isolated, cultured and frozen. If in the future you have to take antibiotics or you experience severe stress, you can take your own bacteria (autoprobiotics). They take root best because the immune system recognizes them as "your own" (immunological tolerance), ensuring perfect and rapid recovery.